Calidi Biotherapeutics, Inc. (CLDI)
0.7946
-0.05
(-6.07%)
USD |
NYAM |
Feb 27, 16:00
0.79
0.00 (0.00%)
After-Hours: 20:00
Calidi Biotherapeutics EPS Diluted (Quarterly) : -2.205 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.85M |
| Total Expenses (Quarterly) | 10.82M |
| Enterprise Value | -1.191M |
| Earnings Yield | -848.7% |
| Normalized Earnings Yield | -848.88 |